The abstract is read at the publisher; the summary is JClub's.
Baseline serum diacylphosphatidylcholine C40:1 predicts postintervention BMI in 50 adults with obesity undergoing a one-year structured lifestyle program.
- Why it matters: Obesity treatment responses vary widely, and clinicians lack reliable baseline markers to forecast who will achieve meaningful weight loss and metabolic improvement.
- What they did: The study profiled clinical measures plus gut microbiome and metabolomics before and after a 3-month ~850 kcal/day formula diet, a 3-month transition (~1000 kcal/day), and 6 months of maintenance up to 2000 kcal/day.
- The result: Serum baseline diacylphosphatidylcholine C40:1 is linked to postintervention BMI, and a random forest using baseline microbial and clinical features predicted weight loss and clinical improvements with high accuracy.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.
- 1 cited this week
- Open access